Top Banner
OPEN INNOVATION – OPPORTUNITIES AND RISKS OF IP TRANSFER ACROSS BORDERS Robert D. Ford February 24, 2011 Innovation Across Borders Conference MaRS Centre, Toronto, Ontario
13
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Innovation Across Borders - Session 5 rob ford

OPEN INNOVATION – OPPORTUNITIES AND RISKS OF

IP TRANSFER ACROSS BORDERS

Robert D. FordFebruary 24, 2011Innovation Across Borders ConferenceMaRS Centre, Toronto, Ontario

Page 2: Innovation Across Borders - Session 5 rob ford

2

Gowlings

One of Canada’s largest national law firms•750 professionals across 8 Canadian offices and

Moscow and London

Cross-disciplinary:•Intellectual Property •Advocacy•Corporate Finance•Licensing, Strategic Alliances and Joint Ventures•Mergers and Acquisitions•Regulatory, Government Relations and Product

Liability services

Page 3: Innovation Across Borders - Session 5 rob ford

3

Business Models for Technology Commercialization

CLOSED INNOVATION - ruled the 20th century

OPEN SOURCE - emerged early 1990s

OPEN INNOVATION - emerged mid-late 1990s

Page 4: Innovation Across Borders - Session 5 rob ford

4

Closed Innovation

• 20th century “Big Business” model

• based on internal / vertical commercialization

• excludes external inputs (except for institutional R&D)

• USA, early 1900s - Europe & Japan early 1950’s

• heyday, 1950s-1980s (Fortune 500 companies)

• Increasing DECLINE 1990s to present

Page 5: Innovation Across Borders - Session 5 rob ford

5

Closed Innovation

Research Productdevelopment

Market

Firm's boundary

Firm's boundary

Product pipeline

Internalresearchprojects

© Henry Chesbrough, 2003, “Open Innovation”

University IP

Govt R&D IP

Firm's boundary

Firm's boundary

Product pipeline

Internalresearchprojects

University IP

Govt R&D IP

Page 6: Innovation Across Borders - Session 5 rob ford

6

• free re-distribution of software in source code form

• shared rights to use the technology

• collaborative further development & sharing of the technology

• no monetary rewards to the innovators

• Open Source IS NOT a sustainable business model

• primarily used by electronic gaming industry & academia

Open Source (Principles)

Page 7: Innovation Across Borders - Session 5 rob ford

7

• mid-1990s – “Closed Innovation” biotechnology commercialization ran into court battles over IP

Open Innovation (Drivers)

• internal projects dropped by Fortune 500 companies = layoffs and unemployment

• unemployed highly trained personnel started companies

• realization that ~90% of IP was not commercialized

Page 8: Innovation Across Borders - Session 5 rob ford

8

• explosion in electronic communications & media

• powerful low cost/no cost internet search engines

• appearance of fast-track commercialization clusters

• evolution of “OPEN INNOVATION” commercialization

Open Innovation (Drivers)

2000’s

Page 9: Innovation Across Borders - Session 5 rob ford

9

• takes advantage of others’ knowledge, successes & IP

Open Innovation (Principles)

• accelerates speed of commercialization

• based on rapid diffusion – adoption – imitation

• requires brokering of knowledge & IP & collaborations

Page 10: Innovation Across Borders - Session 5 rob ford

10

• focus on extensive licensing:• licensing-in• licensing-out• cross-licensing

• greatly expands value capture from protected IP

• patents used as “currency” (not as barriers)

Open Innovation (Principles)

Page 11: Innovation Across Borders - Session 5 rob ford

11

Open Innovation (How it works)

© Chesbrough et al., 2006, “Open Innovation; Researching a New Paradigm””

University IP

Govt R&D IP

Other companies' IP

University IP

Govt R&D IP

Page 12: Innovation Across Borders - Session 5 rob ford

12

The Panel

• Jennifer Thompson, V.P. Corporate Development & Investor Relations EnWave Corporation (TSX-V: ENW)

• Dr. Yousef. Haj-Ahmad, M.Sc., Ph.D.President & CEO, Norgen Biotek Corp.

• Mr. Martin Bonenfant, Intellectual Property Analyst, Medicago Inc.

Page 13: Innovation Across Borders - Session 5 rob ford

13

The Discussion Questions

• How does one protect IP in a global economy?

• What does one "give" and what does one "take" in global collaboration?

• Examples of "open innovation" best practices for SMEs?